FCIClass II
Punch, Biopsy
21 CFR 876.1075 / Gastroenterology, Urology
FCI is the FDA product code for Punch, Biopsy, a class II device type, regulated under 21 CFR 876.1075. As of , FDA records hold 5 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- FCI
- Device name
- Punch, Biopsy
- Regulation
- 21 CFR 876.1075
- Device class
- Class II
- Review panel
- Gastroenterology, Urology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 5
- Ingested recalls
- 0
Clearances, product code FCI
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1983 | 1 |
| 1985 | 1 |
| 1988 | 1 |
| 1989 | 1 |
| 1990 | 1 |
Applicants with the most clearances
Product code FCI| Applicant | Clearances |
|---|---|
| Advanced Diagnostic Medical Systems, Inc. | 1 |
| August C. Stiefel Research Institute, Inc. | 1 |
| Diasonics, Inc. | 1 |
| Integrated Display Technology, Ltd. | 1 |
| National-Standard Co. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code FCI.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
